Language: French
CENTRE LEON BERARD-Medical oncology (Site 0703)
Centre Hospitalier Régional Universitaire de Tours – Hôpital Bretonneau (Site 2602)
Pitie Salpetriere University Hospital (Site 1102)
Centre Hospitalier de Cornouaille Quimper – Concarneau (Site 2600)
centre hospitalier lyon sud (Site 3606)
Institut Universitaire du Cancer Toulouse – Oncopole – CHU de TOULOUSE (Site 0706)
Hopitaux Universitaires Paris Centre-Hopital Cochin (Site 2603)
Institut de Cancérologie de Lorraine Alexis Vautrin (Site 2532)
A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma
This study is a substudy being conducted under one pembrolizumab umbrella master study KEYMAKER-U04. The substudy will consist of 2 parts. Part 1 will evaluate the efficacy and safety of coformulated